The test EVERYONE should get: hsCRP

March 10, 2009

Contact: Lisa Spellman, UNMC Public Relations, (402) 559-4693, lspellman@unmc.edu

News releases are archived on the UNMC Web site at:

https://app1.unmc.edu/publicaffairs/newsarchive/releases.cfm

 

The test EVERYONE should get: hsCRP

 

There are lots of preventive health tests people should get but don’t.

Mammograms, colonoscopies and prostate exams are not exactly high on everyone’s to do list.

 

But there is one test every adult should get, said Scott Shurmur, M.D., a cardiologist and board certified lipidologist and associate professor of internal medicine in cardiology in the University of Nebraska Medical Center College of Medicine..

A simple blood test to check the highly sensitive C-reactive protein or hsCRP.

 

Why?

Because it could save your life.

 

“It has been found that subtle variations in low levels of hsCRP are what really predict heart disease risk,” Dr. Shurmur said.

 

Elevated hsCRP levels indicate vascular inflammation in the arteries of the heart, he said. A normal level is less than 1.0 milligrams per liter, while an elevated level is greater than 3.0 milligrams per liter.

 

This indicates how much plaque is being formed in the arteries and how likely that plague is to rupture and cause a heart attack.

A presentation at the American Heart Association sparked the recent round of interest in hsCRP, Dr. Shurmur said.

 

The presentation focused on results from the investigator initiated JUPITER trial, which suggests that even people with normal cholesterol levels who have elevated hsCRP levels should be on a statin, he said.

 

JUPITER stands for Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin. The trial was funded by AstraZeneca. UNMC was not a participant in the trial.

 

“The trial also showed that statins not only reduce bad cholesterol levels, but also are effective at reducing hsCRP levels,” Dr. Shurmur said.

Even though Crestor was used in the JUPITER trial, he said, all statins lower hsCRP levels. However,some are more effective than others.

 

“Clearly the risk of heart disease increases with age, but athlerosclerosis or plaque build-up is a life-long process,” Dr. Shurmur said. “So it makes sense for people to modify their diet and increase exercise as early in life as possible to decrease their risk.”

 

In his opinion, having a doctor test for hsCRP levels is like having your blood pressure or cholesterol checked.

“It’s not terribly expensive,” Dr. Shurmur said. “It costs no more than routine lab tests.”

And most insurance companies do cover those costs.

 

UNMC is the only public health science center in the state. Its educational programs are responsible for training more health professionals practicing in Nebraska than any other institution. Through their commitment to education, research, patient care and outreach, UNMC and its hospital partner, The Nebraska Medical Center, have established themselves as one of the country’s leading centers in cancer, transplantation biology, bioterrorism preparedness, neurodegenerative diseases, cardiovascular diseases, genetics, biomedical technology and ophthalmology. UNMC’s research funding from external sources now exceeds $82 million annually and has resulted in the creation of more than 2,400 highly skilled jobs in the state. UNMC’s physician practice group, UNMC Physicians, includes 513 physicians in 50 specialties and subspecialties who practice primarily in The Nebraska Medical Center. For more information, go to UNMC’s Web site at www.unmc.edu.

 

-30-